Posted 05 May, 2023
ACELYRIN, Inc. IPO completed
IPO completed detected for ticker Nasdaq:SLRN in a 424B4 filed on 05 May, 2023.
This is our initial public offering, and no public market exists for our common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of ACELYRIN, Inc.
Health Care/Life Sciences • Biotechnology
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.Market Cap
$802M
View Company Details
$802M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.